Impact of diffusion-weighted imaging lesion volume on the success of endovascular reperfusion therapy

Stroke

Volumn 44, Issue 8, 2013, Pages 2205-2211

  Olivot, Jean Marc ^a   Mosimann, Pascal J ^c   Labreuche, Julien ^c   Inoue, Manabu ^a   Meseguer, Elena ^b,c   Desilles, Jean Philippe ^b,c   Rouchaud, Aymeric ^b,c   Klein, Isabelle F ^b   Straka, Matus ^a   Bammer, Roland ^a   Mlynash, Michael ^a   Amarenco, Pierre ^b,c   Albers, Gregory W ^a   Mazighi, Mikael ^b,c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b BICHAT HOSPITAL   (France)

^c INSERM   (France)

Author keywords

acute stroke syndromes; diffusion weighted imaging; endovascular reperfusion; thrombolysis

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BRAIN ISCHEMIA; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECANALIZATION; TREATMENT OUTCOME;

ACUTE STROKE SYNDROMES; DIFFUSION-WEIGHTED IMAGING; ENDOVASCULAR REPERFUSION; THROMBOLYSIS;

AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERY, INTERNAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PROSPECTIVE STUDIES; REGISTRIES; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84880804692     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000911     Document Type: Article

References (31)

1. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007;38:967-973. (Pubitemid 46568460)
2. Alexandrov AV, Demchuk AM, Felberg RA, Christou I, Barber PA, Burgin WS, et al. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranial Doppler monitoring. Stroke. 2000;31:610-614. (Pubitemid 30131644)
3. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, et al. Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke. Stroke. 2000;31:1812-1816. (Pubitemid 30620455)
4. Olivot JM, Mlynash M, Thijs VN, Kemp S, Lansberg MG, Wechsler L, et al. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke. 2008;39:2257-2263.
5. Mazighi M, Serfaty JM, Labreuche J, Laissy JP, Meseguer E, Lavallée PC, et al; RECANALISE Investigators. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confrmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009;8:802-809.
6. Nogueira RG, Lutsep HL, Gupta R, Jovin TG, Albers GW, Walker GA, et al; TREVO 2 Trialists. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012;380:1231-1240.
7. Saver JL, Jahan R, Levy EI, Jovin TG, Baxter B, Nogueira RG, et al; SWIFT Trialists. Solitaire fow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012;380:1241-1249.
8. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. J Am Med Assoc. 1999;282:2003-2011.
9. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet. 2000;355:1670-1674. (Pubitemid 30248478)
10. Hill MD, Rowley HA, Adler F, Eliasziw M, Furlan A, Higashida RT, et al; PROACT-II Investigators. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke. 2003;34:1925-1931. (Pubitemid 36944782)
11. Moseley ME, Kucharczyk J, Mintorovitch J, Cohen Y, Kurhanewicz J, Derugin N, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol. 1990;11:423-429. (Pubitemid 20232815)
12. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293-298. (Pubitemid 46136489)
13. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16:53-59. (Pubitemid 26007950)
14. Thijs VN, Lansberg MG, Beaulieu C, Marks MP, Moseley ME, Albers GW. Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis. Stroke. 2000;31:2597-2602.
15. Oppenheim C, Samson Y, Manaï R, Lalam T, Vandamme X, Crozier S, et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke. 2000;31:2175-2181.
16. Baird AE, Dambrosia J, Janket S, Eichbaum Q, Chaves C, Silver B, et al. A three-item scale for the early prediction of stroke recovery. Lancet. 2001;357:2095-2099. (Pubitemid 32607454)
17. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol. 2009;8:261-269.
18. Dávalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004;62:2187-2192. (Pubitemid 38787773)
19. Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, et al. The MRA-DWI mismatch identifes patients with stroke who are likely to beneft from reperfusion. Stroke. 2008;39:2491-2496.
20. Yoo AJ, Verduzco LA, Schaefer PW, Hirsch JA, Rabinov JD, González RG. MRI-based selection for intra-arterial stroke therapy: value of pre-treatment diffusion-weighted imaging lesion volume in selecting patients with acute stroke who will beneft from early recanalization. Stroke. 2009;40:2046-2054.
21. Rouchaud A, Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, et al. Outcomes of mechanical endovascular therapy for acute isch-emic stroke: a clinical registry study and systematic review. Stroke. 2011;42:1289-1294.
22. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I fndings. N Engl J Med. 1985;312:932-936.
23. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al.; DEFUSE 2 study investigators. MRI profle and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867.
24. Lansberg MG, Lee J, Christensen S, Straka M, De Silva DA, Mlynash M, et al. RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke. 2011;42:1608-1614.
25. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet. 1998;352:1245-1251. (Pubitemid 28470336)
26. Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, et al. Infuence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. J Neurol Sci. 2004;225:3-9. (Pubitemid 39311703)
27. Parsons MW, Christensen S, McElduff P, Levi CR, Butcher KS, De Silva DA, et al; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Pretreatment diffusion-and perfusion-MR lesion volumes have a crucial infuence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab. 2010;30:1214-1225.
28. Mishra NK, Albers GW, Marks MP, Liggins J, Hamilton S, Straka M, et al. Patient selection for endovascular stroke therapy: can MRA substitute for PWI? Stroke. 2013;44:A179. Abstract.
29. Lansberg MG, Thijs VN, Hamilton S, Schlaug G, Bammer R, Kemp S, et al; DEFUSE Investigators. Evaluation of the clinical-diffusion and perfusion-diffusion mismatch models in DEFUSE. Stroke. 2007;38:1826-1830. (Pubitemid 46847254)
30. Mazighi M, Labreuche J, Meseguer E, Serfaty JM, Laissy JP, Lavallée PC, et al. Impact of a combined intravenous/intra-arterial approach in octogenarians. Cerebrovasc Dis. 2011;31:559-565.
31. Chandra RV, Leslie-Mazwi TM, Oh DC, Chaudhry ZA, Mehta BP, Rost NS, et al. Elderly patients are at higher risk for poor outcomes after intra-arterial therapy. Stroke. 2012;43:2356-2361.